SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001387131-20-009681
Filing Date
2020-11-06
Accepted
2020-11-06 17:26:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D tbph-sc13da_102920.htm SC 13D/A 64344
2 FORM LOCK-UP AGREEMENT (DATED AS OF OCTOBER 23, 2020) ex-5.htm EX-5 36401
  Complete submission text file 0001387131-20-009681.txt   102486
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Subject) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90986 | Film No.: 201295413
SIC: 2834 Pharmaceutical Preparations